Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma

被引：20

作者：

Cliff, Edward R. Scheffer ^{[1
]}

Reynolds, Gemma ^{[2
,3
]}

Popat, Rakesh ^{[4
]}

Teh, Benjamin W. ^{[2
,5
]}

Kesselheim, Aaron S. ^{[1
]}

Mohyuddin, Ghulam Rehman ^{[6
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

[2] Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Dept Infect Dis, Melbourne, Vic, Australia

[3] Austin Hlth, Dept Infect Dis, Melbourne, Vic, Australia

[4] Univ Coll London Hosp, NHS Fdn Trust, NIHR UCLH Clin Res Facil, London, England

[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[6] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 10期

关键词：

DEXAMETHASONE; COMBINATION; EFFICACY; SAFETY;

D O I：

10.1200/JCO.22.02197

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1949 / +

页数：4

共 18 条

[1] Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naive to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study [J].

Bahlis, Nizar Jacques ;

Tomasson, Michael H. ;

Mohty, Mohamad ;

Niesvizky, Ruben ;

Nooka, Ajay K. ;

Manier, Salomon ;

Maisel, Christopher ;

Jethava, Yogesh ;

Martinez-Lopez, Joaquin ;

Prince, H. Miles ;

Arnulf, Bertrand ;

Rodriguez Otero, Paula ;

Koehne, Guenther ;

Touzeau, Cyrille ;

Raje, Noopur ;

Iida, Shinsuke ;

Raab, Marc-Steffen ;

Leip, Eric ;

Sullivan, Sharon ;

Conte, Umberto ;

Viqueira, Andrea ;

Lesokhin, Alexander M. .

BLOOD, 2022, 140

[2]

Bumma N, 2022, BLOOD, V140, P10140

[3] Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody [J].

Chari, Ajai ;

Minnema, Monique C. ;

Berdeja, Jesus G. ;

Oriol, Albert ;

van de Donk, Niels W. C. J. ;

Rodriguez-Otero, Paula ;

Askari, Elham ;

Mateos, Maria-Victoria ;

Costa, Luciano J. ;

Caers, Jo ;

Verona, Raluca ;

Girgis, Suzette ;

Yang, Shiyi ;

Goldsmith, Rachel B. ;

Yao, Xiang ;

Pillarisetti, Kodandaram ;

Hilder, Brandi W. ;

Russell, Jeffery ;

Goldberg, Jenna D. ;

Krishnan, Amrita .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24) :2232-2244

[4]

Costa LJ, 2019, BLOOD S1, V134

[5] A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen x CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma [J].

D'Souza, Anita ;

Shah, Nina ;

Rodriguez, Cesar ;

Voorhees, Peter M. ;

Weisel, Katja ;

Bueno, Orlando F. ;

Pothacamury, Rajvineeth K. ;

Freise, Kevin J. ;

Yue, Susan ;

Ross, Jeremy A. ;

Polepally, Akshanth R. ;

Talati, Chetasi ;

Lee, Shane ;

Jin, Ziyi ;

Buelow, Ben ;

Vij, Ravi ;

Kumar, Shaji .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) :3576-+

[6] A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM) [J].

Harrison, Simon J. ;

Minnema, Monique C. ;

Lee, Hans C. ;

Spencer, Andrew ;

Kapoor, Prashant ;

Madduri, Deepu ;

Larsen, Jeremy ;

Ailawadhi, Sikander ;

Kaufman, Jonathan L. ;

Raab, Marc S. ;

Hari, Parameswaran ;

Iida, Shinsuke ;

Vij, Ravi ;

Davies, Faith E. ;

Lesley, Robin ;

Upreti, Vijay V. ;

Yang, Zhao ;

Sharma, Anjali ;

Minella, Alex ;

Lentzsch, Suzanne .

BLOOD, 2020, 136

[7] Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial [J].

Kumar, Shaji K. ;

Harrison, Simon J. ;

Cavo, Michele ;

de la Rubia, Javier ;

Popat, Rakesh ;

Gasparetto, Cristina ;

Hungria, Vania ;

Salwender, Hans ;

Suzuki, Kenshi ;

Kim, Inho ;

Punnoose, Elizabeth A. ;

Hong, Wan-Jen ;

Freise, Kevin J. ;

Yang, Xiaoqing ;

Sood, Anjla ;

Jalaluddin, Muhammad ;

Ross, Jeremy A. ;

Ward, James E. ;

Maciag, Paulo C. ;

Moreau, Philippe .

LANCET ONCOLOGY, 2020, 21 (12) :1630-1642

[8] Bispecific Antibodies in Multiple Myeloma: Present and Future [J].

Lancman, Guido ;

Sastow, Dahniel L. ;

Cho, Hearn J. ;

Jagannath, Sundar ;

Madduri, Deepu ;

Parekh, Samir S. ;

Richard, Shambavi ;

Richter, Joshua ;

Sanchez, Larysa ;

Chari, Ajai .

BLOOD CANCER DISCOVERY, 2021, 2 (05) :423-433

[9] Teclistamab in Relapsed or Refractory Multiple Myeloma [J].

Moreau, Philippe ;

Garfall, Alfred L. ;

van de Donk, Niels W. C. J. ;

Nahi, Hareth ;

San-Miguel, Jesus F. ;

Oriol, Albert ;

Nooka, Ajay K. ;

Martin, Thomas ;

Rosinol, Laura ;

Chari, Ajai ;

Karlin, Lionel ;

Benboubker, Lotfi ;

Mateos, Maria-Victoria ;

Bahlis, Nizar ;

Popat, Rakesh ;

Besemer, Britta ;

Martinez-Lopez, Joaquin ;

Sidana, Surbhi ;

Delforge, Michel ;

Pei, Lixia ;

Trancucci, Danielle ;

Verona, Raluca ;

Girgis, Suzette ;

Lin, Shun X. W. ;

Olyslager, Yunsi ;

Jaffe, Mindy ;

Uhlar, Clarissa ;

Stephenson, Tara ;

Van Rampelbergh, Rian ;

Banerjee, Arnob ;

Goldberg, Jenna D. ;

Kobos, Rachel ;

Krishnan, Amrita ;

Usmani, Saad Z. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06) :495-505

[10] T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervals [J].

Philipp, Nora ;

Kazerani, Maryam ;

Nicholls, Alyssa ;

Vick, Binje ;

Wulf, Jan ;

Straub, Tobias ;

Scheurer, Michaela ;

Muth, Amelie ;

Hanel, Gerulf ;

Nixdorf, Daniel ;

Sponheimer, Monika ;

Ohlmeyer, Malte ;

Lacher, Sonja M. ;

Brauchle, Bettina ;

Marcinek, Anetta ;

Rohrbacher, Lisa ;

Leutbecher, Alexandra ;

Rejeski, Kai ;

Weigert, Oliver ;

von Bergwelt-Baildon, Michael ;

Theurich, Sebastian ;

Kischel, Roman ;

Jeremias, Irmela ;

Bucklein, Veit ;

Subklewe, Marion .

BLOOD, 2022, 140 (10) :1104-1118

← 1 2 →